Y-Intercept (HK)’s iShares US Medical Devices ETF IHI Stock Holding History

Y-Intercept (HK)’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$586K	Buy	+11,447	New	+$605K	0.01%	1239
2026 Q2	–	Sell	-4,327	Closed	-$231K	–	1927
2026 Q1	$231K	Buy	+4,327	New	+$254K	﹤0.01%	1424
2025 Q2	–	Sell	-7,056	Closed	-$425K	–	1800
2025 Q1	$425K	Buy	+7,056	New	+$438K	0.03%	773
2024 Q4	–	Sell	-9,655	Closed	-$572K	–	1408
2024 Q3	$572K	Buy	+9,655	New	+$551K	0.04%	720
2024 Q2	–	Sell	-5,277	Closed	-$309K	–	1620
2024 Q1	$309K	Buy	+5,277	New	+$298K	0.02%	940
2023 Q4	–	Sell	-46,322	Closed	-$2.25M	–	1417
2023 Q3	$2.25M	Buy	46,322 +41,473	+855%	+$2.21M	0.22%	114
2023 Q2	$274K	Sell	4,849 -56	-1%	-$3.08K	0.03%	806
2023 Q1	$265K	Buy	+4,905	New	+$261K	0.03%	831
2022 Q1	–	Sell	-3,932	Closed	-$259K	–	825
2021 Q4	$259K	Sell	3,932 -7,862	-67%	-$503K	0.06%	440
2021 Q3	$740K	Buy	+11,794	New	+$752K	0.13%	238

Other funds holding IHI

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Alaska Permanent Capital Management Anchorage, Alaska $1.5B AUM 10.58% 1-Year Est. Return

RiverFront Investment Group Richmond, Virginia $8.06B AUM 17.38% 1-Year Est. Return

Kingsview Wealth Management Grants Pass, Oregon $8.47B AUM 18.18% 1-Year Est. Return

Y-Intercept (HK)'s IHI Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in iShares US Medical Devices ETF (IHI) in Q3 2026: 11,447 shares worth $586K. The stake represents 0.01% of the portfolio and ranks #1239 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in IHI as recently as Q1 2026.

Y-Intercept (HK) first reported a position in IHI in Q3 2021 and has held it in 10 quarters since. The position peaked at $2.25M in Q3 2023. 395 funds tracked by Wall St. Rank hold IHI as of Q3 2026.

Y-Intercept (HK) held 11,447 shares of iShares US Medical Devices ETF worth $586K as of Q3 2026.
iShares US Medical Devices ETF was a new Y-Intercept (HK) position in Q3 2026.
iShares US Medical Devices ETF made up 0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1239 holding.
Y-Intercept (HK) first reported a position in iShares US Medical Devices ETF in Q3 2021 and has held it in 10 quarters since.
Y-Intercept (HK)'s iShares US Medical Devices ETF position peaked at $2.25M in Q3 2023.
395 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.